IXC
Click for more information
4.29% 6.7¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-6

  1. IndexInvestor
    8,368 Posts.
    lightbulb Created with Sketch. 1379
    clock Created with Sketch.
    04/11/21
    09:34
    Post #: 57303647
    I like that some centres will be in the USA.
    Maybe the USA patients will show significant improvement in PMD and the rest of the world patients won't and all regulators will be happy.
    IXC Price at posting: 65.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.7¢ 		Change
-0.003(4.29%) 		Mkt cap ! $5.035M
Open High Low Value Volume
7.0¢ 7.0¢ 6.7¢ $9.727K 141.0K

Buyers (Bids)

No. Vol. Price($)
1 10000 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 37500 1
View Market Depth
Last trade - 13.44pm 27/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.